Showing 261 - 280 results of 363 for search '(( 12 c decrease ) OR ( 10 ((meters decrease) OR (((nn decrease) OR (mean decrease)))) ))*', query time: 0.24s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268
  9. 269
  10. 270
  11. 271
  12. 272
  13. 273
  14. 274

    Antiferromagnetism in EuPdGe3 by Albedah, M.A.

    Published 2014
    “…EuPdGe3 crystallizes in the BaNiSn3-type tetragonal structure (space group I4mm) with the lattice constants a=4.4457(1)Å and c=10.1703(2)Å. The results are consistent with EuPdGe3 being an antiferromagnet with the Néel temperature TN=12.16(1)K and with the Eu spins S=7/2 in the ab plane. …”
    Get full text
    Get full text
  15. 275
  16. 276

    Hypospadias Reconstruction Training: Development of an Ex-Vivo Model for Objective Evaluation of Surgical Skills by Abbas, Tariq

    Published 2025
    “…However, EMG measurements showed significant reductions in average EMG power, total time, dominant frequency, and cumulative muscle workload after training. Additionally, the mean power spectral density of the EMG signal decreased notably post-training. …”
    Get full text
    Get full text
    Get full text
    article
  17. 277

    Trends and Appropriateness of Sodium-glucose Co-transporter 2 Inhibitors Use in Qatar by Zaghloul, Nancy

    Published 2023
    “…Male gender (odds ratio [OR], 1.692; 95% confidence interval [CI], 1.015 to 2.822; P=0.044), patients with a baseline glycated hemoglobin (HbA1c) >7% (OR, 3.219; 95% CI, 1.838 to 5.637; P<0.001) and atherosclerotic cardiovascular disease (ASCVD) (OR, 2.182; 95% CI, 1.053 to 4.523), patients on metformin (OR, 7.556; 95% CI, 4.460 to 12.802; P<0.001), sulfonylureas (OR, 2.301; 95% CI, 1.160 to 4.563; P=0.017), and dipeptidyl peptidase 4 inhibitors (DPP4is) (OR, 3.430; 95% CI, 2.004 to 5.871; P<0.001) were more likely to be prescribed a SGLT2i. …”
    Get full text
  18. 278
  19. 279
  20. 280